Spire Healthcare Group

Offer for the company

Toscafund made a non-binding 250p proposal on 14 May 2026. Spire and Bidco agreed a recommended 250p cash offer, announced 5 Sep 2026. On 11 Sep 2026 the Panel applied Rule 4.2(c) after a Bidco concert party sold shares without consent. The 30 Sep 2026 H1 results restate the final offer; terms are unchanged and subject to shareholder and regulatory approval.

CEO

Justin Ash retires; Sir David Sloman is interim CEO while a successor is sought 7 Sep 2026 ↗

Chair

Debbie White is interim Chair; Bidco intends to appoint Paolo Pieri after completion 7 Sep 2026 ↗

Breach

Bridgemere sold 22,435,739 shares (about 5.57%) at 245p on 9 Sep 2026 without Panel consent or 24 hours' notice 11 Sep 2026 ↗

Panel ruling

Rule 4.2(c) applies to Bidco: no acquisition of Spire interests; no revision except in exceptional circumstances with Panel consent 11 Sep 2026 ↗

Acceptance

Spire and Bidco have both accepted the ruling 11 Sep 2026 ↗

Restriction

Rule 4.2(c): no revision except in exceptional circumstances with Panel consent 30 Sep 2026 ↗

Next: Court Meeting and General Meeting · 30 Oct 2026

1. 30 Sep 2026 approach
2. 29 Sep 2026 offer
3. 7 Sep 2026 offer · 250p
4. 18 Feb 2026 offer